151636-47-4 Usage
Uses
Used in Organic Synthesis:
(S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane-D-tartrate is used as a catalyst in various organic reactions for its ability to promote a range of transformations, including Michael additions, aldol reactions, and Diels-Alder reactions. Its unique structure and stereochemistry allow for precise control of stereochemical outcomes in these reactions, making it a valuable asset in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
(S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane-D-tartrate is also being studied for its potential pharmacological and biological activities. Its effectiveness as a catalyst in various organic reactions, along with its unique properties, has led to investigations into its potential as a therapeutic agent in various applications, showcasing its versatility and promise in the field of medicine.
Used in Asymmetric Synthesis:
In the field of asymmetric synthesis, (S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane-D-tartrate is used as a chiral catalyst to induce enantioselectivity in chemical reactions. This application is particularly important in the development of pharmaceuticals, where the stereochemistry of a molecule can significantly impact its biological activity and safety profile. (S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane-D-tartrate's ability to control stereochemical outcomes makes it a valuable tool in the synthesis of enantiomerically pure compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 151636-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,6,3 and 6 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 151636-47:
(8*1)+(7*5)+(6*1)+(5*6)+(4*3)+(3*6)+(2*4)+(1*7)=124
124 % 10 = 4
So 151636-47-4 is a valid CAS Registry Number.
151636-47-4Relevant academic research and scientific papers
PHENYLAMINOPYRIMIDINES AND THEIR USE AS RHO-KINASE INHIBITORS
-
Page column 55,56, (2010/02/06)
The invention relates to the phenylaminopyrimidines of formula (I), wherein A, D, R1, R2, R3 and R4 are defined as in the description. The invention also relates to methods for producing said phenylaminopyrimidines and to their use for producing drugs for the treatment and/or the prophylaxis of diseases, especially cardiovascular diseases.
